SI
DGX icon

Stephens Inc’s Quest Diagnostics DGX Stock Holding History

Stephens Inc’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,499
Closed -$254K – 1156
2019
Q2 		$254K Hold
2,499
– – 0.01% 987
2019
Q1 		$225K Buy
+2,499
New +$217K 0.01% 1017
2018
Q4 		– Sell
-2,790
Closed -$301K – 1125
2018
Q3 		$301K Buy
2,790
+372
+15% +$40.8K 0.01% 926
2018
Q2 		$266K Buy
+2,418
New +$252K 0.01% 734
2015
Q1 		– Sell
-13,950
Closed -$935K – 831
2014
Q4 		$935K Buy
13,950
+602
+5% +$38K 0.04% 351
2014
Q3 		$810K Buy
13,348
+1,025
+8% +$63.2K 0.04% 376
2014
Q2 		$723K Buy
12,323
+608
+5% +$35.6K 0.04% 398
2014
Q1 		$679K Buy
+11,715
New +$628K 0.04% 404

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Stephens Inc's DGX Position: Q3 2019 in Review

Stephens Inc sold out of Quest Diagnostics (DGX) in Q3 2019, closing a stake of 2,499 shares — an estimated $254K sold.

Stephens Inc first reported a position in DGX in Q1 2014 and held it in 8 quarters. The position peaked at $935K in Q4 2014. 677 funds tracked by Wall St. Rank hold DGX as of Q3 2019.

  • Stephens Inc reported no remaining Quest Diagnostics position as of Q3 2019 after selling out during the quarter.
  • Stephens Inc sold 2,499 Quest Diagnostics shares in Q3 2019, an estimated $254K.
  • Stephens Inc first reported a position in Quest Diagnostics in Q1 2014 and held it in 8 quarters.
  • Stephens Inc's Quest Diagnostics position peaked at $935K in Q4 2014.
  • 677 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2019.

Based on Stephens Inc's 13F filing for Q3 2019, filed 18 Oct 2019.